Ana-isabel Teruel
Valencia, VC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Single-point and kinetics of peripheral residual disease by mass spectrometry to predict outcome in patients with high-risk smoldering multiple myeloma included in the GEM-CESAR trial.
Journal: Haematologica
Published: April 23, 2024
Correction: Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role.
Journal: Leukemia
Published: March 09, 2019
Predicting long-term disease control in transplant-ineligible patients with multiple myeloma: impact of an MGUS-like signature.
Journal: Blood cancer journal
Published: September 13, 2018
Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical Trials.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 13, 2017
Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role.
Journal: Leukemia
Published: April 19, 2017
Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients.
Journal: Blood
Published: March 12, 2016
Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under LenDex: a longitudinal analysis.
Journal: Blood
Published: October 08, 2015
Sequential vs alternating administration of VMP and Rd in elderly patients with newly diagnosed MM.
Journal: Blood
Published: August 25, 2015
Last Updated: 09/26/2026